Atomo Diagnostics Limited
Research Atomo Diagnostics Limited (AT1.AX) on Bullrun: market cap AUD 15.34M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAT1.AX
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryMedical Devices
- CurrencyAUD
- Market capAUD 15.34M
- Financial periodFY2026
- RevenueAUD 5.23M
- Revenue growth60.9%
- Net income-AUD 3.51M
- Free cash flow-AUD 3.40M
- Gross margin33.9%
Valuation Snapshot
latest market cap is AUD 15.34M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | AUD 5.23M | -AUD 3.51M | -AUD 3.40M | 33.9% | n/a | AUD 3.71M | AUD 373.08K | AUD 7.71M |
| FY2025 | AUD 3.25M | -AUD 4.97M | -AUD 1.99M | 42.3% | -0.01 | AUD 3.22M | AUD 185.10K | AUD 6.98M |
| FY2024 | AUD 4.09M | -AUD 6.85M | -AUD 4.70M | 39.3% | -0.01 | AUD 3.69M | AUD 141.19K | AUD 10.08M |
| FY2023 | AUD 2.54M | -AUD 9.96M | -AUD 6.25M | 26.2% | -0.02 | AUD 6.47M | AUD 254.88K | AUD 14.79M |
| FY2022 | n/a | n/a | n/a | n/a | -0.01 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-16 | AUD 15.34M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About Atomo Diagnostics Limited
Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. The company offers blood test devices, such as Pascal, Curie, Galileo, Elion, and Florey under the AtomoRapid brand. It also offers HIV Rapid self-testing programs; and digital health solutions. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Atomo Diagnostics Limited's market cap?
Atomo Diagnostics Limited's market capitalization is AUD 15.34M.
What does Atomo Diagnostics Limited do?
Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. The company offers blood test devices, such as Pascal, Curie, Galileo, Elion, and Florey under the AtomoRapid brand. It also offers HIV Rapid self-testing programs; and digital health solutions. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.